TASHA COCKRUM: Open Payments
NPI 1689110066 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,581 in 180 payments from 28 companies in 2025. Trend: 2023 $1,957 · 2024 $3,526 · 2025 $3,581
Food & beverage: $3,497Education: $84
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $351 |
| ABBVIE INC. | 27 | $296 |
| EMD Serono, Inc. | 11 | $251 |
| PFIZER INC. | 13 | $241 |
| Alexion Pharmaceuticals, Inc. | 8 | $235 |
| Eisai Inc. | 14 | $229 |
| ACADIA Pharmaceuticals Inc | 10 | $225 |
| UCB, Inc. | 11 | $206 |
| SK Life Science, Inc. | 10 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $169 |
Products named: Symbravo, Leqembi, ULTOMIRIS, NUPLAZID, NURTEC ODT, HYQVIA, UBRELVY, VYEPTI.
Industry payments across CA — which companies pay providers there.
